BICO Group logo

BICO Group

Stock
Stock
ISIN: SE0013647385
Ticker: BICO
SE0013647385
BICO

Price

Price

Frequently asked questions

What is BICO Group's market capitalization?

The market capitalization of BICO Group is $216.46M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for BICO Group?

BICO Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.376. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for BICO Group's stock?

Currently, 3 analysts cover BICO Group's stock, with a consensus target price of $9.957. Analyst ratings provide insights into the stock's expected performance.

What is BICO Group's revenue over the trailing twelve months?

Over the trailing twelve months, BICO Group reported a revenue of $203.88M.

What is the EBITDA for BICO Group?

BICO Group's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $37.07M. EBITDA measures the company's overall financial performance.

What is the free cash flow of BICO Group?

BICO Group has a free cash flow of -$3.24M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of BICO Group's stock?

The 5-year beta for BICO Group is 1.91. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does BICO Group have, and what sector and industry does it belong to?

BICO Group employs approximately 828 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of BICO Group's shares?

The free float of BICO Group is 43.94M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$216.46M

5Y beta

 
1.91

EPS (TTM)

 
-$1.376

Free Float

 
43.94M

Revenue (TTM)

 
$203.88M

EBITDA (TTM)

 
$37.07M

Free Cashflow (TTM)

 
-$3.24M

Pricing

1D span
$3.056$3.322
52W span
$3.019$6.858

Analyst Ratings

The price target is $9.957 and the stock is covered by 3 analysts.

Buy

3

Hold

0

Sell

0

Information

BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

828

Medical Equipment & Supplies

Health Care

Identifier

ISIN

SE0013647385

Primary Ticker

BICO

Knockouts

Join the conversation